Company Overview and News

0
MFM steady despite 1H ‘storm’

2018-08-13 theedgemarkets
KUALA LUMPUR: Between January and June this year, grain and poultry player Malayan Flour Mills Bhd (MFM) faced a “perfect storm” — in the words of chief financial officer (CFO) Cheang Kiat Cheong — that was the culmination of a rare combination of adverse factors that affected the company simultaneously.
3662

0
KLCI seen consolidating gains, tracking mixed global markets.

2018-07-19 theedgemarkets
KUALA LUMPUR (July 20): The FBM KLCI is seen consolidating its gains around the 1,750-point level today, against the backdrop of mixed equity markets around the world.
1023 5238 7245 BATS 4162 3662 CIMDF

0
AirAsia, AirAsia X, APFT, BAT, CIMB, Malayan Flour Mills, PUC, Serba Dinamik and WZ Satu

2018-07-19 theedgemarkets
KUALA LUMPUR (July 19): Based on corporate announcements and news flow today, companies that may be in focus on Friday (July 20) may include the following: AirAsia, AirAsia X, APFT, BAT, CIMB, Malayan Flour Mills, PUC, Serba Dinamik and WZ Satu.
FLY 5238 7245 BATS 4162 SMHS 3662

0
MFlour proposes to raise up to RM275 mil via rights issue of RCULS and shares

2018-07-19 theedgemarkets
KUALA LUMPUR (Jul 19): Malayan Flour Mills Bhd is making a cash call to raise up to RM275.1 million for the expansion of its poultry processing plant, construction of a new aqua feed milling plant, the extension of an existing jetty, as well as to pare down its revolving credit facilities.
3662

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...